To explore whether tumor growth promoted by USP9X is due to deubiquitinate EGLN3, clone growth assay demonstrated that increased cell proliferation was impaired by knockout of EGLN3 in HUCCT and RBE cell (Additional file 2: Figure S5B-S5F). The gene discussed is USP9X; the disease is neoplasm.